Tech Company Financing Transactions
Cylex Funding Round
Canaan Partners, Channel Medical Partners and Siemens Venture Capital invested in a $20.5 million Series C funding round for Cylex. This VC investment round was announced on 3/7/2007.
Transaction Overview
Company Name
Announced On
3/7/2007
Transaction Type
Venture Equity
Amount
$20,500,000
Round
Series C
Investors
Proceeds Purpose
Cylex CEO Judith A. Britz said in an interview Cylex will use the funding to boost its penetration into the transplant market, expand research and development and sales, and explore new uses of its technology for immune monitoring products targeting infectious diseases and autoimmune disorders. The company currently employs 38 and show grow to more than 50 by the end of the year.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
8980 Old Annapolis Rd.
Columbia, MD 21045
USA
Columbia, MD 21045
USA
Phone
Website
Email Address
Overview
Cylex operates as a life sciences company that develops, manufactures, and commercializes in vitro diagnostic products such as ImmuKnow.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
President
Brad Stewart
VP - Customer Service
Sharlene Blum
VP - Human Resources
Dena Meagher
VP - Operations
Marc Berman
VP - Product Management
Jianrong Lou
Browse more venture capital transactions:
Prev: 3/6/2007: Eons venture capital transaction
Next: 3/7/2007: ENOVIX venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs